Surfactants in Bioformulation: Are We at the End or the Beginning of a Journey?

3/22/2022 09:55 - 10:25

  • Excipient impact on biologics formulations
  • Stability studies related to chemical and enzymatic degradation
  • Reduction of mAB- and protein aggregates
  • Excipient safety, e.g. Poloxamer 188 (Kolliphor® P 188 Bio), Polysorbates 20 and 80, Kolliphor® HS 15, Kolliphor® ELP

Philipp Hebestreit, Regional Technical Service Manager , BASF